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Introduction
Human brucellosis is a common zoonotic infection 
and is still prevalent in many countries of Africa, Mid-
dle East, the Mediterranean area, Indian subcontinent, 
Central America and Central Asia (Papas et al. 2006). 
In the Middle East, the incidence of human Brucellosis 
was the highest during the 1990s, although a gradual 
decline in incidence has been witnessed afterward; still, 
Saudi Arabia is considered an endemic zone for Brucel-
losis. The clinical manifestation of the disease constitutes 
a  broad range of signs and symptoms. Patients com-
monly present with fever, chills, fatigue, joint, muscle 
and back pain. The fact that symptoms are non-specific 
and can be shared by other infectious diseases makes it 
even more difficult for clinicians to diagnose it clinically.
Although the diagnosis is confirmed by isolation 
of the Brucella spp. from tissues or body fluids, the 
occupational risk of infection transmission to labora-
tory staff and the time-consuming and less sensitive 
culture examination has led to consider other diag- 
nostic techniques more useful in the diagnostic workup 
of brucellosis.
Serologically, ELISA is the most popular and widely 
used diagnostic assay. Brucella-specific IgM antibodies 
are produced in the first week after the disease onset, 
reaching a maximum after two months. On the other 
hand, IgG antibodies are detected after the second week 
of infection, attaining a peak level of six to eight weeks 
later. While IgG response coincides more closely with 
the clinical course, the detection of specific IgM anti-
body in the absence of specific IgG antibody might be 
confusing for treating physician and therefore risks 
misdiagnosis of active brucellosis. Likewise, clinical 
interpretation of Brucella-specific IgG antibodies in the 
absence of IgM also creates confusion for clinicians. 
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A b s t r a c t
Non-specific and often misleading clinical presentation of active brucellosis has made it a diagnostic puzzle for treating physicians. Clinicians 
rely greatly on the detection of IgG and IgM anti-Brucella antibodies by ELISA. Different patterns of positivity have been observed for IgG and 
IgM anti-Brucella antibodies in different cases, which further increases the risk of an erroneous diagnosis. Detailed herein is our two-years 
data with varied Brucella serology patterns and their clinical interpretation. Between January 2015 to December 2017, 1102 samples were 
processed in the Immunology Laboratory of KFHU for Brucella serology. 68 samples were positive for both IgG and IgM, 28 samples were 
positive for IgG and negative for IgM while 15 samples were positive for IgM and negative for IgG antibodies against Brucella. Electronic 
medical records, history of exposure, signs, symptoms, laboratory data, and the final diagnosis were recorded for all these patients. None 
of the patients with only positive IgM antibodies was finally diagnosed with brucellosis, while a diagnosis of brucellosis was established for 
only one patient with IgG antibodies positive in his serum. All the double-positive (IgG- and IgM-positive) serology patterns were diagnosed 
as having brucellosis. We concluded that determination of single IgM or IgG anti-Brucella-antibodies by ELISA could both be considered 
as definite and should ideally be interpreted in the context of appropriate clinical scenario and confirmation by other laboratory assays.
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While some studies conducted on the diagnostic 
accuracy of ELISA mentioned a combined specificity 
of 100% for Brucella-specific IgM and IgG (Özdemir 
et al. 2011; Asaad et al. 2012), some other studies also 
highlighted the possible detection of Brucella-specific 
antibodies in cases without active brucellosis. Litera-
ture review reveals a great variation between studies 
performed on the sensitivity and specificity of Brucella-
specific IgM and IgG antibodies detected by ELISA. 
Gomez et al. (2008) assigned a combined specificity of 
100% for IgG and IgM and individual sensitivity of 60% 
and 84% for IgM and IgG, respectively. Mantur et al. 
(2010), on the other hand, reported a combined IgM 
and IgG ELISA specificity of 71.3% and a combined 
sensitivity of 100 %. Welch et al. (2010) found a com-
bined specificity and a combined sensitivity of 55% 
and 92.3%, respectively. While anti-Brucella antibody 
detection does not always indicate brucellosis, a nega-
tive antibody profile does not exclude the infection, so 
results of Brucella serology should be interpreted with 
great caution (Welch et al. 2010).
Experimental
Materials and Methods
A retrospective search was performed on the serum 
samples that were analyzed by ELISA for the presence 
of IgG and IgM anti-Brucella antibodies at the Immu-
nology Laboratory of King Fahad Hospital of the Uni-
versity (KFHU) from January 2015 to December 2017. 
Our hospital mainly serves eastern region population 
of Saudi Arabia and just like other provinces, overall 
incidence of brucellosis has decreased significantly in 
the eastern province. The ethical review board of KFHU 
approved the study protocol.
A total number of 1051 patients were evaluated for 
the presence of Brucella-specific antibodies. Out of 
these patients 512 (46%) were females and 590 (53%) 
were males. Mean age of the patient was 37 ± 12 years. 
Electronic files of these patients were reviewed for their 
detailed medical records including age, gender, pre-
vious history of exposure, signs, symptoms, the results 
of other laboratory tests to support the diagnosis of bru-
cellosis (culture, rapid slide agglutination assay), and 
the number of times the serology was repeated for each 
patient. Final diagnosis, antibiotic treatment, and all 
other relevant clinical information were also recorded 
for the patients from progress and discharge notes of 
the treating physician.
IgG and IgM ELISA were performed using 
Abcam kits (Cambridge, UK; Cat #ab100547 and Cat 
#ab214568, respectively). All the steps were performed 
following instructions from the manufacturer. Sera and 
controls (50 µl) were dispensed to the antigen-coated 
wells of micro-test plates followed by first incubation 
for 60 min at 37°C. The wells were then washed fol-
lowed by addition of anti-human IgG or IgM antibod-
ies conjugated with an alkaline phosphatase enzyme. 
Later ELISA plates were incubated for another 30 min 
at 37°C and well were washed again. Enzyme substrate 
(50 µl) was then added to all wells followed by another 
incubation for 30 min and finally the stopping solution 
was added to all wells to inhibit the reaction. The color 
intensity was measured by ELISA reader.
IgG and IgM values above 11 standard units were 
considered positive. Values between 9 and 11 were con-
sidered uncertain while antibody levels below 9 stand-
ard units were considered negative for both IgM and 
IgG Brucella antibodies.
Blood culture was performed using a minimum 
of two culture set (one aerobic and one anaerobic) 
from two different venipuncture sites using a volume 
of 7–10 ml blood per vial for adult and 1–5 ml blood 
per vial for pediatric. All the vials were loaded to the 
Baltic system, which detected any CO2 level change in 
blood culture vial as an indicator of the growth of the 
organisms. On identifying specific vial with CO2 level 
change, subculture was performed for the sample using 
four plates (5% blood agar plate, Chocolate blood agar, 
MacConkey agar plate, and Brucella selective media).
RSAT (Rapid Slide Agglutination Assay Test) was 
performed using Atlas Medical Kits (Cambridge, UK; 
Cat #8.01.15.0.0010). All the steps were performed fol-
lowing instructions from the manufacturer. One drop 
(50 µl) each of serum and control was dispensed into 
separate circles on the slide test followed by one drop 
(50 µl) of the antigen into each well. Slides were placed 
on a mechanical rotator for one minute and agglutina-
tion was noted in bright indirect light.
Results
A total of 1102 samples were processed in the Immu-
nology Laboratory of KFHU over a period of two years 
from January 2015 to December 2017 and ELISA sero-
logy was performed on them for IgM and IgG anti-
Brucella antibodies.
Out of these samples, 991 were negative for both 
IgG and IgM antibodies, 68 samples were positive for 
both IgG and IgM, 28 samples were positive for IgG 
and negative for IgM while 15 samples were positive for 
IgM and negative for IgG antibodies against Brucella.
68 double-positive (IgG- and IgM-positive) samples 
belonged to 38 patients. The number of times sero-
logy was repeated for these patients and the number 
of times the result was the same (IgG and IgM posi-
tive) ranged between 2 and 5. The Brucella culture was 
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advised for all of these patients and turned out positive 
for 36 of them. RSAT was requested for only 13 patients 
and turned out positive for all of these double positive 
patients (Table I).
We have further divided single-positive patients 
into two groups. The first group included patients with 
serology positive for IgG and negative for IgM and the 
second group included patients who were positive for 
IgM and negative for IgG against Brucella.
Patients who had positive IgG and negative IgM 
anti-Brucella antibodies. The 28 samples positive 
for IgG and negative for IgM anti-Brucella antibod-
ies belonged to 22 patients. The number of times per 
patient when the serology was IgG-Brucella positive 
and IgM-Brucella negative ranged between 1 and 5 
(Table  I). Of these patients, 81% (n = 18) were males 
while 19% (n = 4) were females. The age range of these 
patients varied from 7 to 64 years.
Of the 22 patients, two had additional risk factors of 
possible exposure to Brucella spp. other than residing 
in a Brucella-endemic country. One was a worker in 
a local slaughterhouse while other was a medical labo-
ratory technologist. Both were residents of Dammam 
city, which lies in the Eastern province of Saudi Arabia.
Most common presenting complaint was fever fol-
lowed by musculoskeletal pain. 12 patients presented 
with fever while five patients had joint-related symp-
toms that led the physician to request serology. Other 
symptoms leading to a serological assessment of Bru-
cella antibodies included abdominal pain, pancyto-
penia, and dizziness.
RSAT test was requested for only two patients and 
the serology was negative for both. Blood culture for 
Brucella was performed for 21 out of 22 patients and 
turned out negative for all of them but one patient for 
whom the diagnosis of brucellosis was confirmed. Sero-
logy was requested for antinuclear antibodies (ANA) 
for all five patients with musculoskeletal symptoms. 
Four out of five patients demonstrated the presence of 
ANA in their sera. Anti-VCA-IgM and Monospot tests 
were positive in one patient and therefore a diagnosis of 
EBV-mononucleosis was established. Another patient 
was diagnosed as having HIV based on positive HIV 
serology on one occasion followed by a positive HIV-
PCR. Hepatitis B surface antigen was detected in the 
serum of one patient that led to the final diagnosis of 
hepatitis B. In another patient, the diagnosis of syphilis 
was established after the demonstration of antibodies 
against Treponema pallidum in his serum.
The definite clinical diagnosis of these patients is 
presented in Table II. Out of 12 patients that presented 
with fever, the infectious cause was identified in seven 
with only one patient diagnosed with active brucel-
losis. Out of five patients with musculoskeletal pains, 
three were diagnosed as having connective tissue dis-
ease, while polyarthralgia and mechanical neck pain 
was a diagnosis in remaining two. Out of three patients 
with the symptoms of abdominal pain, one patient with 
accompanying fever was diagnosed as having syphilis, 
while the other two were diagnosed with self-limited 
abdominal pain and prostate malignancy. The diagno-
sis of lymphoproliferative disorder was established in 
one patient with pancytopenia. Stroke was the diagno-
sis in one patient with the weakness of limbs. No final 
diagnosis could be established in the remaining two 
patients who presented with dizziness and were treated 
symptomatically by the local physician.
Patients who had positive IgM and negative IgG 
anti-Brucella antibodies. All the 15 samples positive 
for IgM and negative for IgG belonged to 15 patients 
and serology was not repeated for these patients. The 
age of these patients at which serology was requested 
ranged from 14 to 40 years. 53% (n = 8) of these IgM-
positive and IgG-negative patients were male, while 
47% (n = 7) were females.
Other than the risk of living in a high prevalence 
country, one patient had an additional risk of working 
as a nurse in the infectious diseases clinic for two years.
Fever was the most common presenting symptom 
and the reason behind requesting Brucellosis workup 
in eight out of 15 patients. Joint pains became the sec-
ond most common cause leading to request ELISA 
for anti-Brucella antibodies. Other causes leading to 
request Brucella serology included a cough associated 
with chest pain in two patients and hematuria in one 
patient. Only one patient presented with splenomegaly 
and abdominal pain.
RSAT was performed for 13 patients and turned out 
positive for four patients and culture was performed 
for 13 patients and turned out negative for all of them. 
The final diagnosis for each patient with IgM positive 
and IgG negative anti-Brucella antibodies is presented 
in Table III.
Not a single patient was diagnosed as having bru-
cellosis. Of all the patients that presented with fever, 
one had influenza while another had syphilis as defi-
nite diagnosis after demonstration of positive the Influ-
enza PCR and the Syphilis-Ig, respectively. Pyrexia of 
unknown origin (PUO) was diagnosed in two patients 
1 IgG–IgM– 991 976 1
2 IgG+IgM+ 68 38 2–5
3 IgG+IgM– 28 22 1–5
4 IgG–IgM+ 15 15 0
Table I
The serology patterns for Brucella-specific antibodies (ELISA).
Serology
Pattern
Number
of Patients
Number
of Samples
Number of times
serology was repeated
with the same results
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with fever. In another two patients, the diagnosis of 
acute cystitis and spondylarthrosis was established. 
Tuberculosis and community-acquired pneumonia 
remained the final diagnosis in two patients that pre-
sented with a cough and chest pain. In four patients, 
the demonstration of antinuclear antibodies (ANA) 
led to the diagnosis of systemic lupus erythematosus 
(SLE). Cervicalgia was diagnosed in one patient who 
presented with shoulder pain while another patient 
with arthralgia was diagnosed with multiple sclerosis. 
One patient with hematuria as the chief presenting 
complaint was diagnosed as having renal stones.
Discussion
Saudi Arabia is considered a high prevalence zone 
for brucellosis and the prevalence is higher in a rural 
community as compared to urban areas. Non-specific 
presentation and a high index of suspicion on part of 
local physicians enabled us to describe a large series of 
patients who presented to the KFUH ID clinic with the 
clinical picture suggestive of brucellosis and variable 
patterns of serology results. Most common symptoms 
were fever and musculoskeletal pains.
Serology was performed by ELISA for all patients. 
Different patterns of positivity were observed for IgG 
and IgM anti-Brucella antibodies in these patients. 
Other laboratory assays that were performed to con-
firm the diagnosis included blood culture for Brucella 
and RSAT.
ELISA has a diagnostic advantage over other sero-
logical assays in an endemic setting where is a need to 
process a huge number of samples. However, sensitivity 
and specificity of IgG and IgM anti-Brucella antibodies 
have been a topic of debate in many studies (Gomez 
et al. 2008). Presence of IgM antibodies is indicative of 
acute infection but at the same time, IgM antibodies are 
well known for their cross-reactions with other bacte-
rial species, like Yersinia, Escherichia coli O157, Salmo-
 1 48 yr M No Arthralgia Culture negative, ANA positive Connective tissue disease
 2 45 yr F No Fever, knee joint pain Culture negative, Rubella IgG Connective tissue disease
     positive, ANA positive
 3 59 yr M No Paralysis (TIA) Culture negative Stroke
 4 36 yr M No Fever, cough,  Culture negative Tuberculosis
 5 31 yr M No Fever and fatigue Culture negative, Monospot  EBV – infectious
     positive, VCA-IgM positive mononucleosis
 6 35 yr F No Joint pain Culture negative, ANA positive Polyarthralgia
 7  7 yr M No Fever Culture negative, RSAT negative Meningitis
 8 34 yr M Worker at Fever Culture positive, VCA-IgM negative Brucellosis
   slaughter-
   -house
 9 35 yr M No Fever, fatigue, malaise Culture negative PUO
10 45 yr M No High-grade fever Culture negative Self-limited febrile syndrome
11 64 yr M No Fever and weight loss Culture negative, HIV-Ab positive HIV
12 27 yr M No Fever and low BP Culture and RSAT negative Septic shock of unknown origin
13 17 yr M No Fatigue and dizziness Culture negative –
14 26 yr M No dizziness – –
15 46 yr M No Pancytopenia Culture negative Lymphoproliferative disease
16 17 yr F No Joint pain Culture negative, ANA positive Connective Tissue Disease
17 31 yr F No Fever Culture negative PUO
18 17 yr M No Fever and abdominal pain Culture negative, Syphilis-Ig positive Syphilis
19 28 yr M No Abdominal pain Culture negative Self-limited unspecified
      abdominal pain
20 44 yr M Medical Generalized abdominal pain Culture negative Prostate malignancy
   laboratory
   Technologist
21 22 yr M No Neck and right shoulder pain Culture negative, ANA negative Mechanical neck pain
22 32 yr M No Low-grade fever Culture negative, HBsAg positive Hepatitis-B
Table II
Patients with positive IgG and negative IgM anti-Brucella antibodies.
Age Sex Risk factors Symptoms Other diagnostic tests Final diagnosis
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nella spp. and Francisella tularenis (Aranis et al. 2008). 
Since infections have been identified as the cause of 
fever in most of our patients, cross-reactions are prob-
ably responsible for the detection of IgM anti-Brucella 
antibodies in these patients.
Out of 53 patients who had IgM-antibodies in their 
sera, 38 were also positive for IgG and all of these 
double-positive patients were diagnosed for brucello-
sis based on suggestive clinical picture and isolation 
of the organism from the blood culture. None of the 
15 patients who had only IgM antibodies against Bru-
cella in their sera were actually diagnosed as having 
active brucellosis.
Furthermore, the other possible reason for false pos-
i tive IgM antibodies could be the presence of rheuma-
toid factor (ISCIII 2018). Therefore, it is recommended 
to remove rheumatoid factor by pre-absorption before 
the determination of IgM anti-Brucella antibodies in 
sera to avoid possible interference with the result. One 
study has described a positivity of 8.8% for rheuma-
toid factor in patients with osteoarticular brucellosis 
(Corbel et al. 1985). Since most of the patients with 
IgM only antibodies in their sera presented with fever 
and joint-related symptoms and none of the sample 
was pre-treated to absorb rheumatoid factor, the false 
positivity of IgM antibodies can be attributed to inter-
ference due to rheumatoid factor.
Mantecón et al. (2006) have described IgG anti-
Brucella antibodies more sensitive as compared to IgM 
in the diagnosis of brucellosis. Just like IgM anti bodies, 
cross-reactivity leading to a false positivity has been 
described for IgG anti-Brucella antibodies. Binnicker 
et al. (2012) reported cross-reactivity of IgG with 
syphilis, while Varshoch et al. (2011) documented that 
tuberculosis might result in false-positive IgG anti- 
bodies. Similarly, in our series of patients, we found 
out a number of different infections leading to false-
positive determination of IgG antibodies, including 
tuberculosis, syphilis, infectious mononucleosis, HIV 
and hepatitis B infections.
Only one patient with IgG only antibodies detected 
in his serum was diagnosed with brucellosis on con-
firmation by isolation of Brucella spp. from his blood 
culture. A possible explanation for the absence of IgM 
antibodies in this patient could be the fact that excess 
of IgG can lead to false-negative IgM in some immu-
noassays (Sharma et al. 2008). Al Dahouk et al. (2011) 
reported 11% of the patients with acute brucellosis to 
be negative for IgM antibodies.
The RSAT is considered a suitable screening test 
for the diagnosis of brucellosis; however, considering 
a great proportion of false-positive and false-negative 
results reported by RSAT, it is recommended to use 
a  supplementary laboratory technique like ELISA or 
Table III
Patients with positive IgM and negative IgG anti-Brucella antibodies.
Age Sex Risk factors Symptoms Other diagnostic tests Final diagnosis
 1 14 yr F No Chest pain, cough and fever Negative blood culture and RSAT URTI
 2 30 yr M No Shoulder pain Negative blood culture and RSAT Cervicalgia
 3 40 yr F No Fever and arthralgia Negative blood culture and positive RSAT Acute cystitis
 4 32 yr F No Abdominal pain and Negative blood culture and RSAT,  SLE
    splenomegaly ANA positive
 5 22 yr F No Arthralgia – Multiple sclerosis
 6 37 yr F No Fever and back ache – Spondylarthrosis
 7 25 yr M No Fever and body aches Positive Syphilis-Ig, Negative blood Syphilis, HTN
     culture and RSAT
 8 17 yr M No Myalgia and arthralgia Positive ANA, Negative blood Connective tissue
     culture and RSAT disease/SLE
 9 31 yr F No Arthralgia Positive ANA and dsDNA, Negative blood SLE
     culture and positive RSAT
10 24 yr M Nurse in Fever and fatigue Negative blood culture and positive RSAT PUO
   a Medical Unit
11 30 yr M No Fever and Myalgia Influenza PCR positive, Negative Influenza
     blood culture and positive RSAT
12 30 yr F No Backache Negative blood culture and negative RSAT,  CTD/SLE
     ANA positive
13 39 yr M No Fever cough chest pain Negative RSAT Community acquired
    hemoptysis  pneumonia
14 22 yr M No Hematuria Negative blood culture and negative RSAT Renal stones
15 24 yr M No Fever Negative blood culture and negative RSAT PUO
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MAT to further confirm the results of RSAT (Geresu 
et al. 2016). Four out of 13 patients with IgM only 
antibodies against Brucella in their sera were reported 
a positive by RSAT. Since none of these patients were 
diagnosed with brucellosis, the cross-reactions respon-
sible for false-positive IgM were possibly leading to 
false-positive RAST results in these patients.
Different studies carried out on the sensitivity and 
specificity of IgG and IgM anti-Brucella antibodies 
reveal a great degree of variation. Furthermore, vari-
ability between the ability of different commercial 
IgM and IgG ELISA kits to diagnose brucellosis should 
be taken into account. A study conducted by Fadeel 
et al. (2011) evaluated the performance of four com-
mercial kits for diagnosing brucellosis. Most of the 
investigation concluded the sensitivity of more than 
90% for all kits with variable specificity. None of the 
kits obtained 100% diagnostic accuracy for diagnos-
ing brucellosis. Authors further concluded that sensiti- 
vity of ELISA is increased when the levels of IgG and 
IgM against Brucella are considered in combination 
and that sero logy results should be interpreted in tan-
dem with clinical history, symptoms of patients and 
other diagnostic tests. We found a sensitivity and spe-
cificity of 99% and 36%, respectively for Brucella-spe-
cific IgG ELISA. The individual sensitivity and specific-
ity of Brucella-specific IgM were calculated to be 97% 
and 58%, respectively, when compared to bacterial 
culture. We further reported combined IgM and IgG 
ELISA specificity of 94% and a combined sensitivity 
of 98%, which is in accordance with above-mentioned 
studies (Welch et al. 2010) and therefore can help 
improve clinicians confidence in cases with double-
positive (IgG+/IgM+) serology.
Being retrospective research, our study is subjected 
to some limitations. It was not possible to compare 
ELISA results with the MAT, the gold standard for sero-
logical diagnosis, to rule out false-positive and false-
negative results for the determination of IgG and IgM 
anti-Brucella antibodies. Nevertheless, in our study, 
the false-positive results of IgM and IgG anti-Brucella 
antibodies may be supported by other diagnostic 
assays like blood culture and by taking into account the 
history and clinical course. Therefore, we believe that 
our results are in the clinical interest of the physicians 
who find it challenging to interpret different patterns 
of serology results by ELISA.
To conclude, the combined sensitivity of IgG and 
IgM against Brucella is higher when compared to 
individual sensitivity of IgG or IgM antibodies in the 
diagnosis of brucellosis. In case of positive IgM-only 
antibodies, the test should be repeated after preabsorp-
tion of the sample to remove rheumatoid factor. Our 
study highlighted the significance of cross-reactions 
leading to false-positive level of antibodies and there-
fore overdiagnosis of brucellosis in a region where 
medical conditions like tuberculosis, syphilis and con-
nective tissue disorder can possibly simulate brucello-
sis. We further concluded that determination of IgG 
only or IgM only anti-Brucella-antibodies by ELISA 
should not be regarded as definite and should be inter-
preted in the context of appropriate clinical scenario 
and confirmation by other laboratory assays like MAT 
(Poester et al. 2010).
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